Behavioral Health Market Analysis

  • Report ID: 4441
  • Published Date: Jun 10, 2025
  • Report Format: PDF, PPT

Behavioral Health Segmentation

Disorder (Depression, Anxiety, Substance Abuse)

Based on disorder, the depression segment is expected to garner the highest share of 32.9% in the behavioral health market by the end of 2037. The dominance of the segment is highly attributed to the increasing burden of depression among the worldwide population and exclusive treatment innovation by the global organizations. The WHO report in 2024 estimates that over 270 million individuals will be seeking care by the assessed timeframe, increasing by 50% due to the expanded awareness. Besides novel therapies such as NMDA modulators, accelerate market upliftment with USD 1.3 billion in yearly sales of Sapravato, thereby providing a positive segment outlook.

Service (Outpatient Counseling, Emergency Mental Health Services, Home-Based Telehealth, Inpatient Hospital Treatment, Residential Support)

Based on the service, the home-based telehealth segment is projected to grow at a considerable rate, with a share of 28.5% in the behavioral health market during the forecast period. The segment’s growth originates from the continuous and rigorous demand for home-based services. For instance, in 2024, CMS data unveiled that claims for telehealth are at a surge by 300% from 2022 to 2024, owing to the permanent reimbursement policies offering coverage for USD 6.8 billion in a year in behavioral health services. With the presence of virtual platforms such as Talkspace, the cost gets reduced by 35% per patient, hence creating an optimistic opportunity for the segment’s growth.

Our in-depth analysis of the behavioral health market includes the following segments:

Disorder

  • Depression
  • Anxiety
  • Substance Abuse
  • Others

Service

  • Outpatient Counseling
  • Emergency Mental Health Services
  • Home-Based Telehealth
  • Inpatient Hospital Treatment
  • Residential Support

Treatment Modality

  • Pharmacotherapy
  • Psychotherapy
  • Digital Therapeutics
  • Neuromodulation (TMS, DBS)

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of the behavioral health market was over USD 225.8 billion.

The market size for the behavioral health market is projected to reach USD 420.7 billion by the end of 2037, expanding at a CAGR of 6.2% during the forecast period, i.e., between 2025-2037.

The major players in the market are Johnson & Johnson, Pfizer, Eli Lilly, Novartis, Roche, GlaxoSmithKline (GSK), and others.

In terms of the disorder segment, the depression segment is anticipated to garner the largest market share of 32.9% by 2037 and display lucrative growth opportunities during 2025-2037.

The market in North America is projected to hold the largest market share of 42.6% by the end of 2037 and provide more business opportunities in the future.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos